Bio*One Capital's A-Bio Pharma Secures A Second Deal With GlaxoSmithKline
$9 million Expansion of Facility Underway
This deal follows the first project with GSK Bio that was announced in November 2004 as well as the master service agreement with Novo Nordisk A/S in May 2005.
With the securing of these agreements as well as a few more in the pipeline, there will be a further investment of S$9 million (US$5.5 million) to expand A-Bio's cell culture manufacturing capacity to meet increasing customer demand. A-Bio will add a 500L stirred tank bioreactor to its existing 200L capacity.
Most read news
Organizations
Other news from the department manufacturing
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.